FDA Approves Argenx’s Vyvgart Hytrulo Prefilled Syringe For Self-Injection For At Home Use Setting

FDA approves Argenx’s Vyvgart Hytrulo prefilled syringe for self-injection in gMG and CIDP, offering flexible dosing and expanding treatment options. Latest Ratings for ARGX Date Firm Action From To Mar 2022 Morgan Stanley Maintains Equal-Weight Feb 2022 Morgan Stanley Maintains Equal-Weight Jan 2022 Morgan Stanley Maintains Equal-Weight View More Analyst Ratings for ARGX View the…

Read More

Tariffs May Have Mixed Effects On Carmax, May Boost Used Car Demand Due To Pricier New Cars: Analyst

CarMax Inc (NYSE:KMX) posted a 5.1% rise in same-store used vehicle sales in Q4, signaling a rebound from prior softness. Despite macroeconomic uncertainty, the company reaffirmed its long-term goals while enhancing omnichannel efforts and improving SG&A efficiency. Latest Ratings for KMX Date Firm Action From To Feb 2022 Evercore ISI Group Downgrades Outperform In-Line Jan…

Read More